š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This multi-center, randomized, double-blinded, placebo-controlled, dose-ran...
Status
Completed
Location
Praxis Research Site
Start Date
2021-10-14
Trial ID
NCT05021991
Treatments Being Tested
This was a phase 1, first-in-human, single-center, randomized, double-blind...
Status
Completed
Location
Clinical Trial Site
Start Date
2017-11-28
Trial ID
NCT05047458
The primary aim of the trial is to compare the influence of MICARDISĀ® (telm...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02200653
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
The primary aim of this study is to quantify the effectiveness of Bactrim a...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-05
Trial ID
NCT00676130
Treatments Being Tested
Determination of the effects of sildenafil citrate and epoprostenol when us...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-07
Trial ID
NCT00159861
Treatments Being Tested
Primary Trial objectives: To evaluate the pharmacokinetics and -dynamics o...
Status
Completed
Location
ABX-CRO
Start Date
2009-10
Trial ID
NCT01043146
This is a Phase 1, randomized, double blind (sponsor open), parallel, place...
Status
Completed
Location
P-one clinic, Keikokai medical corporation
Start Date
2020-10-26
Trial ID
NCT04552470
Treatments Being Tested
This is a multi-centre, long term, double blind, clinical protocol for Nana...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11
Trial ID
NCT04808531
Treatments Being Tested
To explore the effectiveness of of MDMA-assisted prolonged exposure therapy...
Status
Unknown
Location
Drug Health Services, Royal Prince Alfred Hospital
Start Date
2023-09-19
Trial ID
NCT05709353
Treatments Being Tested